Anti-™EM167B monoclonal antibody

Pre-made anti-™EM167B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM167B/™EM167B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2006-Ab-1/ GM-Tg-hg-IP2006-Ab-2Anti-Human ™EM167B monoclonal antibodyHuman
GM-Tg-rg-IP2006-Ab-1/ GM-Tg-rg-IP2006-Ab-2Anti-Rat ™EM167B monoclonal antibodyRat
GM-Tg-mg-IP2006-Ab-1/ GM-Tg-mg-IP2006-Ab-2Anti-Mouse ™EM167B monoclonal antibodyMouse
GM-Tg-cynog-IP2006-Ab-1/ GM-Tg-cynog-IP2006-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM167B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2006-Ab-1/ GM-Tg-felg-IP2006-Ab-2Anti-Feline ™EM167B monoclonal antibodyFeline
GM-Tg-cang-IP2006-Ab-1/ GM-Tg-cang-IP2006-Ab-2Anti-Canine ™EM167B monoclonal antibodyCanine
GM-Tg-bovg-IP2006-Ab-1/ GM-Tg-bovg-IP2006-Ab-2Anti-Bovine ™EM167B monoclonal antibodyBovine
GM-Tg-equg-IP2006-Ab-1/ GM-Tg-equg-IP2006-Ab-2Anti-Equine ™EM167B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2006-Ab-1/ GM-Tg-hg-IP2006-Ab-2; GM-Tg-rg-IP2006-Ab-1/ GM-Tg-rg-IP2006-Ab-2;
GM-Tg-mg-IP2006-Ab-1/ GM-Tg-mg-IP2006-Ab-2; GM-Tg-cynog-IP2006-Ab-1/ GM-Tg-cynog-IP2006-Ab-2;
GM-Tg-felg-IP2006-Ab-1/ GM-Tg-felg-IP2006-Ab-2; GM-Tg-cang-IP2006-Ab-1/ GM-Tg-cang-IP2006-Ab-2;
GM-Tg-bovg-IP2006-Ab-1/ GM-Tg-bovg-IP2006-Ab-2; GM-Tg-equg-IP2006-Ab-1/ GM-Tg-equg-IP2006-Ab-2
Products NameAnti-™EM167B monoclonal antibody
Formatmab
Target Name™EM167B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM167B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2006-Ag-1Recombinant multi-species KISHB/ ™EM167B/ AD-020 protein
    ORF Viral VectorpGMLP001261human ™EM167B Lentivirus plasmid
    ORF Viral VectorvGMLP001261human ™EM167B Lentivirus particle
    ORF Viral VectorpGMLPm002354mouse Tmem167b Lentivirus plasmid
    ORF Viral VectorvGMLPm002354mouse Tmem167b Lentivirus particle


    Target information

    Target IDGM-IP2006
    Target Name™EM167B
    Gene ID56900,67495,499690,697418,100688675,101097330,613426,100629819
    Gene Symbol and Synonyms2010200O16Rik,AD-020,C1orf119,C3H1orf119,RGD1564454,™EM167B
    Uniprot AccessionQ9NRX6,Q0IIL4
    Uniprot Entry NameKISHB_HUMAN,KISHB_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000215717
    Target ClassificationN/A

    The target: ™EM167B, gene name: ™EM167B, also named as AD-020, C1orf119. Involved in constitutive secretory pathway. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.